← FDA Drug Approvals (Drugs@FDA)

ALBENDAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LTD · Approved 2018-09-21

Drug application

FDA Application #

ANDA210434

Application type

Abbreviated New Drug Application (Generic)

Brand name

ALBENDAZOLE

Generic name

Albendazole

Active ingredients

ALBENDAZOLE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

CIPLA LTD

First approval

2018-09-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown